[go: up one dir, main page]

BR9203798A - Formulacao de liberacao prolongada,processo para preparar uma formulacao e processo para aumentar o crescimento em um animal - Google Patents

Formulacao de liberacao prolongada,processo para preparar uma formulacao e processo para aumentar o crescimento em um animal

Info

Publication number
BR9203798A
BR9203798A BR929203798A BR9203798A BR9203798A BR 9203798 A BR9203798 A BR 9203798A BR 929203798 A BR929203798 A BR 929203798A BR 9203798 A BR9203798 A BR 9203798A BR 9203798 A BR9203798 A BR 9203798A
Authority
BR
Brazil
Prior art keywords
formulation
animal
prepare
prolonged release
increase growth
Prior art date
Application number
BR929203798A
Other languages
English (en)
Inventor
Norman Dale Brooks
Gregory Frank Needham
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/934,017 external-priority patent/US5352662A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9203798A publication Critical patent/BR9203798A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BR929203798A 1991-10-01 1992-09-29 Formulacao de liberacao prolongada,processo para preparar uma formulacao e processo para aumentar o crescimento em um animal BR9203798A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76955591A 1991-10-01 1991-10-01
US07/934,017 US5352662A (en) 1991-10-01 1992-08-21 Injectable extended release formulations and methods

Publications (1)

Publication Number Publication Date
BR9203798A true BR9203798A (pt) 1993-04-27

Family

ID=27118187

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929203798A BR9203798A (pt) 1991-10-01 1992-09-29 Formulacao de liberacao prolongada,processo para preparar uma formulacao e processo para aumentar o crescimento em um animal

Country Status (13)

Country Link
EP (1) EP0535899A1 (pt)
JP (1) JPH05194273A (pt)
CN (1) CN1071845A (pt)
AU (1) AU652284B2 (pt)
BR (1) BR9203798A (pt)
CA (1) CA2079541A1 (pt)
CZ (1) CZ294992A3 (pt)
FI (1) FI924335A7 (pt)
HU (1) HUT66070A (pt)
IL (1) IL103275A0 (pt)
MX (1) MX9205508A (pt)
NO (1) NO923763L (pt)
NZ (1) NZ244550A (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW282403B (pt) * 1993-08-26 1996-08-01 Takeda Pharm Industry Co Ltd
ATE287673T1 (de) * 1995-06-07 2005-02-15 Southern Biosystems Inc Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US5817627A (en) * 1996-06-14 1998-10-06 Theratechnologies Inc. Long-acting galenical formulation for GRF peptides
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CA2507522C (en) 2002-12-13 2015-02-24 Durect Corporation Oral drug delivery system
PT1809329E (pt) 2004-09-17 2012-03-29 Durect Corp Composição anestésica local prolongada contendo aibs
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
EP2484347A1 (en) 2006-11-03 2012-08-08 Durect Corporation Transdermal delivery systems comprising bupivacaine
EP2067471B1 (en) 2007-12-06 2018-02-14 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
AU2014233453A1 (en) 2013-03-15 2015-10-01 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CA3028450A1 (en) 2016-07-06 2018-01-11 Durect Corporation Oral dosage form with drug composition, barrier layer and drug layer
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579911D1 (de) * 1984-12-24 1990-10-31 Sumitomo Pharma Stabiles grf-praeparat.
CA1285874C (en) * 1985-08-23 1991-07-09 Thomas Harry Ferguson Injectable sustained release formulation
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
ATE74009T1 (de) * 1986-08-11 1992-04-15 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use

Also Published As

Publication number Publication date
JPH05194273A (ja) 1993-08-03
NZ244550A (en) 1994-03-25
FI924335L (fi) 1993-04-02
CZ294992A3 (en) 1993-04-14
FI924335A0 (fi) 1992-09-28
MX9205508A (es) 1993-07-01
EP0535899A1 (en) 1993-04-07
FI924335A7 (fi) 1993-04-02
CN1071845A (zh) 1993-05-12
AU652284B2 (en) 1994-08-18
AU2600992A (en) 1993-04-08
HUT66070A (en) 1994-09-28
HU9203102D0 (en) 1992-12-28
IL103275A0 (en) 1993-02-21
CA2079541A1 (en) 1993-04-02
NO923763D0 (no) 1992-09-28
NO923763L (no) 1993-04-02

Similar Documents

Publication Publication Date Title
BR9205142A (pt) Composicao inseticida,e,processo para produzi-la
BR9203798A (pt) Formulacao de liberacao prolongada,processo para preparar uma formulacao e processo para aumentar o crescimento em um animal
FI20050467L (fi) Menetelmiä kasvuhormonin vapautumisen edistämieksi eläimessä
BR9202522A (pt) Composto,formulacao farmaceutica e processo para preparar um composto
BR9201859A (pt) Processo para a reducao do teor de componentes contendo fosforo em oleos vegetais e animais
BR9607061A (pt) Processo para redução de crescimento de pelos em mamíferos uso de um composto de catequina processo para produção de uma composição para a redução de crescimento de pelos em mamíferos e composição quando usada para inibir o crescimento de pelos em mamíferos
BR9105570A (pt) Composicao de polimero estabilizada,e processo para formar uma estrutura conformada
BR9007911A (pt) Concentrado emulsionavel estavel,processo para tratamento de plantas,e de praga em animais,composicao para uso na formacao de concentrado emulsionavel,composicao compreendendo o concentrado emulsionavel,e processo para controle da populacao de pragas agricolas
BR8906832A (pt) Composicao e processo para combater insetos
BR9204191A (pt) Composicao de isca e processo para controlar populacoes de besouro diabroticine,e isca
BR9301342A (pt) Composto,formulacao e composicao farmaceutica,processo para preparar um composto
FI954497A7 (fi) Aktiivista ainetta sisältävä laastari estradiolin vapauttamiseksi ihoo n
BR8900743A (pt) Derivados de pirazol,composicao inseticida e acaricida,composicao fungicida e processo para produzir derivados de pirazol
BR9100196A (pt) Composicao herbicida e processo para produzir derivados de uracil
BR8900303A (pt) Composicao herbicida e processo para controlar ervas daninhas
PT87968A (pt) Processo para a preparacao de 5,6-dimetoxi-1,2-benzimidazolo-3-propanaminas substituidas em n e de compostos relacionados e de composicoes farmaceuticas que os contem
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
BR8703764A (pt) Processo para controlar o crescimento de ervas daninhas em um local,produto e composicao herbicida
BR9203796A (pt) Composicao e processo para regular o crescimento de plantas
MX164816B (es) Composicion y metodo para producir 1,3,5-trinitro-2,4,6-tripicrilbenceno
BR8900169A (pt) Composicao inseticida,processo para induzir o acumulo de tetrapirrois em insetos vivos e processo para matar insetos
BR9102563A (pt) Processo aperfeicoado para depliacao de peles animais
BR9100443A (pt) Dispositivo para aplicar ingrediente ativo em inseto
BR9401235A (pt) Fumigante, composição, e, processo para aperfeiçoar a taxa de volatilização de ingrediente ativo em um fumigante
BR9102635A (pt) Derivado de pirazolcarboxamida,composicao fungicida e acaricida e processo para produzir derivado de pirazolcarboxamida

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C07K 14/60 (2006.01), A61K 9/00 (2006.0